Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sézary syndrome from other cutaneous T-cell lymphomas.
about
Dynamic changes in cellular infiltrates with repeated cutaneous vaccination: a histologic and immunophenotypic analysis.Extracorporeal photopheresis for the treatment of erythrodermic cutaneous T-cell lymphoma: a single center clinical experience with long-term follow-up data and a brief overview of the literature.Genetic markers associated with progression in early mycosis fungoides.Paucity of intraepidermal FoxP3-positive T cells in cutaneous T-cell lymphoma in contrast with spongiotic and lichenoid dermatitis.High-scatter T cells: a reliable biomarker for malignant T cells in cutaneous T-cell lymphoma.Sézary syndrome is a unique cutaneous T-cell lymphoma as identified by an expanded gene signature including diagnostic marker molecules CDO1 and DNM3.Guidelines on the use of extracorporeal photopheresisOsteosarcoma microenvironment: whole-slide imaging and optimized antigen detection overcome major limitations in immunohistochemical quantification.CD8(+)/FOXP3(+)-ratio in osteosarcoma microenvironment separates survivors from non-survivors: a multicenter validated retrospective study.The effect of extracorporeal photopheresis alone or in combination therapy on circulating CD4(+) Foxp3(+) CD25(-) T cells in patients with leukemic cutaneous T-cell lymphoma.Dimethyl fumarate restores apoptosis sensitivity and inhibits tumor growth and metastasis in CTCL by targeting NF-κB.Expression of T-plastin, FoxP3 and other tumor-associated markers by leukemic T-cells of cutaneous T-cell lymphoma.Regulatory T cells and immunodeficiency in mycosis fungoides and Sézary syndrome.Prognostic factors, prognostic indices and staging in mycosis fungoides and Sézary syndrome: where are we now?FOXP3 positive regulatory T-cells in cutaneous and systemic CD30 positive T-cell lymphoproliferations.FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival.Histopathological and immunophenotypical criteria for the diagnosis of Sézary syndrome in differentiation from other erythrodermic skin diseases: a European Organisation for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force StudRegulation gone wrong: a subset of Sézary patients have malignant regulatory T cells.Intracerebral human regulatory T cells: analysis of CD4+ CD25+ FOXP3+ T cells in brain lesions and cerebrospinal fluid of multiple sclerosis patients.Reciprocal modulation of circulating CD4+CD25+bright T cells induced by extracorporeal photochemotherapy in cutaneous T-cell lymphoma and chronic graft-versus-host-disease patients.Analysis of FOXP3+ regulatory T cell subpopulations in peripheral blood and tissue of patients with systemic lupus erythematosus.The role of regulatory T cells and genes involved in their differentiation in pathogenesis of selected inflammatory and neoplastic skin diseases. Part II: The Treg role in skin diseases pathogenesis.Overexpression of hypoxia-inducible factor 1 alpha impacts FoxP3 levels in mycosis fungoides--cutaneous T-cell lymphoma: clinical implications.FoxP3-Positive T-Regulatory Cells in Lymph Nodes with Mycosis Fungoides and Sézary Syndrome
P2860
Q30434822-F926AA31-4422-41BD-AC4D-261F8158C424Q30650570-0FE9641D-A62C-4CE0-B79E-0136047DB43CQ33556038-85632D47-C307-4BBB-A0E0-91F13183B904Q33835381-76AA8BF8-3895-4135-823F-E440C7609686Q34667769-5DBB9A64-4D28-468C-B48C-6B5C0D771F18Q34717463-2D857A3A-14E8-4EBA-8507-E0AAEE74BC91Q34918643-E823FC26-430E-4E4E-B6B5-450DB439FDA2Q35110990-38E07544-0BDC-4DFD-BFBB-370E65F930D1Q35506606-7A805452-E755-4352-96B0-46F17FFA48DEQ35858578-7878CDDA-222C-4CBA-A4B0-C464ECCC0299Q37262461-2BEFE889-9F57-499C-B5FF-63A0CCAB2119Q37698501-B4ACC355-9E75-4941-9226-B7BEEC87A75CQ37929548-38B08606-7DF1-4EA9-8E20-D9C67999E30FQ38196931-B9DDB28F-547F-44D8-9995-46B7CB70FF8CQ40003943-0C087DAD-A159-4C35-94BF-C98682996FD4Q40090775-64249E68-8A63-4FED-B719-A873D573C2CFQ41086530-069A195B-D200-4A2C-A2E0-C158345487FDQ41849574-EAEC4CCE-6D5B-4B65-B9F6-CEAB0B42220EQ41869890-EAC7FE45-8553-46E4-9899-BB6D86B8EE50Q44951228-7AF3EDC7-3AF7-44AE-9EDD-D9E2653F41F5Q52787680-09D6F6E5-3AD5-4C24-84C0-0AFEE3B426DEQ54261770-711E7FA6-C1A5-47D9-91F6-AF3D608FD16BQ54758764-204D7DFB-BE27-45EC-B871-6F6CDC2F161DQ59050199-56B37706-4E04-4933-A8E0-8827BA9DCEC4
P2860
Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sézary syndrome from other cutaneous T-cell lymphomas.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Paucity of FOXP3+ cells in ski ...... er cutaneous T-cell lymphomas.
@en
type
label
Paucity of FOXP3+ cells in ski ...... er cutaneous T-cell lymphomas.
@en
prefLabel
Paucity of FOXP3+ cells in ski ...... er cutaneous T-cell lymphomas.
@en
P2093
P2860
P356
P1433
P1476
Paucity of FOXP3+ cells in ski ...... her cutaneous T-cell lymphomas
@en
P2093
Fritzsching B
Kleinmann EV
Krammer PH
Suri-Payer E
P2860
P2888
P304
P356
10.1038/SJ.LEU.2404182
P577
2006-06-01T00:00:00Z
P5875
P6179
1024935789